Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532434) titled 'A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer' on April 8.

Study Type: Observational [Patient Registry]

Primary Sponsor: Peking University Third Hospital

Condition: Ovarian Cancer Breast Cancer

Recruitment Status: Recruiting

Date of First Enrollment: September 30, 2025

Target Sample Size: 480

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07532434

Disclaimer: Curated by HT Syndication....